A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia
收藏DataCite Commons2025-03-04 更新2024-07-13 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005197/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to demonstrate that a paliperidone palmitate 3 month formulation (PP3M) is as effective as the paliperidone palmitate 1 month formulation (PP1M) in the treatment of patients with schizophrenia who have been stabilized on PP1M.
提供机构：
Vivli
创建时间：
2020-02-04
